Floatz logo

Iron

Celiac Disease

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Celiac Disease cohort.

Asset / SponsorPhaseRating
Necator Americanus
James Cook University, Queensland, Australia
Phase 2BB
Larazotide
9 Meters Biopharma, Inc.
Phase 3BB
Prolyl Endopeptidase
Dr. C. Bonorino Udaondo Gastroenterology Hospital
Phase 4BB
Latiglutenase
Entero Therapeutics
Phase 2BB
MACROGOLS
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BB

View all 50 →

Same molecule, other indications

Iron is also rated in:

iron deficiency anemiaDormant
BB
Indicative ·
71 / 100
View asset →
AnemiaDormant
BB
Indicative ·
68 / 100
View asset →
Obesity, ChildhoodDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →